v3.26.3
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Summary of Segment Information for Revenue, Significant Segment Expenses and Net Loss as Regularly Provided to the CODM

The following table presents segment information for revenue, significant segment expenses, and net loss, as regularly provided to the CODM, for the three and nine months ended September 30, 2026 and 2025 (in thousands):

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenue

$

42

 

 

$

16

 

 

$

86

 

 

$

71

 

Less:

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

61

 

 

 

41

 

 

 

153

 

 

 

122

 

Payroll related expenses

 

4,225

 

 

 

4,360

 

 

 

14,310

 

 

 

12,252

 

Consulting and professional fees

 

1,450

 

 

 

1,514

 

 

 

5,014

 

 

 

5,389

 

Stock-based compensation expense

 

1,281

 

 

 

1,254

 

 

 

2,939

 

 

 

4,091

 

Equipment, lab supplies, and facility expenses

 

369

 

 

 

422

 

 

 

1,036

 

 

 

1,225

 

Clinical studies and outside processing

 

111

 

 

 

394

 

 

 

387

 

 

 

1,111

 

Depreciation and amortization(1)

 

163

 

 

 

214

 

 

 

489

 

 

 

609

 

Other segment items(2)

 

1,269

 

 

 

797

 

 

 

4,009

 

 

 

2,822

 

Loss from operations

 

(8,887

)

 

 

(8,980

)

 

 

(28,251

)

 

 

(27,550

)

Interest expense

 

(2

)

 

 

(2

)

 

 

(5

)

 

 

(8

)

Other income, net

 

836

 

 

 

1,168

 

 

 

2,665

 

 

 

3,511

 

Net loss

$

(8,053

)

 

$

(7,814

)

 

$

(25,591

)

 

$

(24,047

)

 

(1)
Certain amortization amounts are included within cost of revenue.
(2)
Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expenses.